CFGS
ABBV icon

Concourse Financial Group Securities’s AbbVie ABBV Stock Holding History

Concourse Financial Group Securities’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-16,060
Closed -$2.74M – 6
2024
Q4 		$2.74M Sell
16,060
-395
-2% -$72.6K 0.16% 140
2024
Q3 		$3.25M Buy
16,455
+1,355
+9% +$253K 0.19% 121
2024
Q2 		$2.59M Buy
15,100
+139
+0.9% +$23K 0.16% 137
2024
Q1 		$2.72M Buy
14,961
+149
+1% +$25.7K 0.18% 128
2023
Q4 		$2.3M Sell
14,812
-1,078
-7% -$157K 0.16% 131
2023
Q3 		$2.37M Buy
15,890
+136
+0.9% +$20K 0.18% 121
2023
Q2 		$2.12M Buy
15,754
+347
+2% +$50.9K 0.16% 127
2023
Q1 		$2.46M Buy
15,407
+3,584
+30% +$548K 0.19% 118
2022
Q4 		$1.91M Buy
+11,823
New +$1.81M 0.15% 148
2022
Q3 		– Sell
-11,008
Closed -$1.58M – 1976
2022
Q2 		$1.69M Buy
11,008
+235
+2% +$35.9K 0.14% 158
2022
Q1 		$1.75M Sell
10,773
-5,818
-35% -$845K 0.13% 166
2021
Q4 		$2.25M Sell
16,591
-630
-4% -$74.4K 0.13% 153
2021
Q3 		$1.86M Sell
17,221
-176
-1% -$20.1K 0.11% 174
2021
Q2 		$1.96M Buy
17,397
+338
+2% +$38.1K 0.12% 154
2021
Q1 		$1.85M Sell
17,059
-188
-1% -$20.1K 0.13% 142
2020
Q4 		$1.85M Buy
17,247
+515
+3% +$49.5K 0.14% 137
2020
Q3 		$1.47M Buy
16,732
+1,288
+8% +$121K 0.13% 142
2020
Q2 		$1.52M Sell
15,444
-2,400
-13% -$211K 0.15% 126
2020
Q1 		$1.36M Buy
17,844
+2,342
+15% +$199K 0.15% 134
2019
Q4 		$1.37M Buy
15,502
+10,058
+185% +$835K 0.14% 133
2019
Q3 		$412K Sell
5,444
-8,760
-62% -$601K 0.1% 160
2019
Q2 		$1.03M Buy
14,204
+3,266
+30% +$257K 0.1% 159
2019
Q1 		$880K Buy
10,938
+57
+0.5% +$4.66K 0.09% 183
2018
Q4 		$1M Buy
10,881
+8,610
+379% +$757K 0.12% 150
2018
Q3 		$215K Buy
+2,271
New +$215K 0.06% 269

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Concourse Financial Group Securities's ABBV Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of AbbVie (ABBV) in Q1 2025, closing a stake of 16,060 shares — an estimated $2.74M sold.

Concourse Financial Group Securities first reported a position in ABBV in Q3 2018 and held it in 25 quarters. The position peaked at $3.25M in Q3 2024. 3,819 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining AbbVie position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 16,060 AbbVie shares in Q1 2025, an estimated $2.74M.
  • Concourse Financial Group Securities first reported a position in AbbVie in Q3 2018 and held it in 25 quarters.
  • Concourse Financial Group Securities's AbbVie position peaked at $3.25M in Q3 2024.
  • 3,819 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.